Mavyret approved as 8-week treatment for hep C, compensated cirrhosis

(HealthDay)—Approval of Mavyret (glecaprevir and pibrentasvir) tablets has been expanded to eight-week treatment for treatment-naive patients aged 12 years and older with chronic hepatitis C virus (HCV) genotypes 1 through 6 and compensated cirrhosis, the U.S. Food and Drug Administration announced last week. Mavyret is the first eight-week treatment approved Continue Reading

Barrier to rural opioid treatment: Driving distance to methadone clinics

People who live in rural counties in five states heavily affected by the opioid epidemic must drive longer distances to obtain methadone, a treatment for opioid addiction, compared to individuals from urban counties, say Yale researchers. Their study, published in the Journal of the American Medical Association (JAMA), suggests these Continue Reading

Virtual reality treatment could help military veterans suffering with post-traumatic stress disorder

Virtual reality technology could be used to help military veterans suffering from post-traumatic stress disorder (PTSD), a new study concludes. Researchers and clinicians at Cardiff University and within NHS Wales have completed a randomized controlled trial of the new therapy, known as 3MDR (multi-modular motion-assisted memory desensitization and reconsolidation), among Continue Reading

New treatment improves survival in women newly diagnosed with advanced ovarian cancer

An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces their risk of relapse or death from this disease. The Primary Investigator of this study is Dr. Antonio González Martín from Clinica Universidad de Navarra Continue Reading

Tailoring treatment for preterm infants born with heart defects

The nonsteroidal anti-inflammatory drug indomethacin is routinely used to treat patent ductus arteriosus (PDA), a persistent opening between the aorta and pulmonary artery that is a common complication in preterm infants. Clinical response and toxicity to indomethacin are highly variable. About one in four infants treated with indomethacin requires subsequent Continue Reading

Many patients not receiving first-line treatment for sinus, throat, ear infections

Investigators have now shown that only half of patients presenting with sinus, throat, or ear infections at different treatment centers received the recommended first-line antibiotics, well below the industry standard of 80 percent. The research is published this week in Antimicrobial Agents and Chemotherapy, a journal of the American Society Continue Reading

Study assesses asthma treatment options in African American children and adults

A new study of African Americans with poorly controlled asthma, found differences in patients’ responses to commonly used treatments. Contrary to what researchers had expected, almost half of young children in the study responded differently than older children and adults, and than white children in prior studies. “We shouldn’t assume Continue Reading

Scientists identify a possible new treatment for diabetic retinopathy

About one in three diabetic patients develops diabetic retinopathy (DR), which can impair vision and lead to blindness. A new study in The American Journal of Pathology, published by Elsevier, provides clear evidence that high glucose increases the levels of enzymatic precursor—lysyl oxidase propeptide (LOX-PP)—that promotes cell death, which was Continue Reading